Suven Life Sciences Hits 52-Week High, Outperforms Sector by 6.02%
Suven Life Sciences, a smallcap pharmaceutical company, reached a 52-week high on September 16, 2024, with a 6.71% increase in today's trading. The stock has outperformed the sector by 6.02% and is currently trading higher than its moving averages. With a strong performance of 117.09% in the past year, the company shows potential for growth in the pharmaceutical industry.
Suven Life Sciences, a smallcap pharmaceutical company, has recently hit a 52-week high on September 16, 2024. The stock has been given a 'Sell' call by MarketsMOJO, a leading financial analysis platform.
The stock has shown a strong performance today, outperforming the sector by 6.02%. This is a significant increase from its previous 52-week high of Rs. 161.4. The stock has also shown a trend reversal, gaining after two consecutive days of fall.
In today's trading, Suven Life Sciences reached an intraday high of Rs. 161.4, showing a 6.71% increase. The stock is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.
In the past year, Suven Life Sciences has shown an impressive performance of 117.09%, while the Sensex has only shown a 22.19% increase. This showcases the company's strong growth and potential in the pharmaceutical industry.
Investors and experts are closely watching Suven Life Sciences as it continues to make strides in the market. With its recent 52-week high and positive performance, the company is definitely one to keep an eye on.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
